- conhecimento Artigos &publicações Sentinel lymph node biopsy following neoadjuvant chemotherapy: an evidence-based review and recommendations for current practiceRandomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement statusReal-world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: Correlation of pathological complete response with overall survivalPrognostic Factors and Survival Outcomes of Patients With Early HER2+ Breast Cancer Treated With Trastuzumab in a Brazilian Public Reference Center: A Real-World StudyEpidemiology of male breast cancer in Brazil: An analysis of patients undergoing treatment in the public health systemHow long does it take to start breast cancer treatment in Brazil? Is the 60-day law fulfilled?Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 studyAGE OF DIAGNOSIS AND BODY MASS INDEX IN BREAST CANCER PATIENTS: ANALYSIS OF A BRAZILIAN REFERENCE CENTREA phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patientsEstrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer « Entradas Mais Antigas Próximas Entradas »
Sentinel lymph node biopsy following neoadjuvant chemotherapy: an evidence-based review and recommendations for current practice
Randomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement status
Real-world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: Correlation of pathological complete response with overall survival
Prognostic Factors and Survival Outcomes of Patients With Early HER2+ Breast Cancer Treated With Trastuzumab in a Brazilian Public Reference Center: A Real-World Study
Epidemiology of male breast cancer in Brazil: An analysis of patients undergoing treatment in the public health system
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
AGE OF DIAGNOSIS AND BODY MASS INDEX IN BREAST CANCER PATIENTS: ANALYSIS OF A BRAZILIAN REFERENCE CENTRE
A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
